CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-01 | McMurry-Heath Michelle Director | Grant or award · Restricted Stock Units | +1,157 | 1,157 | ||
| 2021-10-29 | Vizirgianakis Stavros G. Director | Grant or award | +2,780,923 | 2,780,923 | ||
| 2021-10-29 | Beyer Pat Director | Grant or award · Stock Option (Right to Buy) | +34,906 | 34,906 | ||
| 2021-10-29 | Beyer Pat Director | Grant or award · Restricted Stock Units | +2,895 | 2,895 | ||
| 2021-10-29 | Vizirgianakis Stavros G. Director | Grant or award · Stock Option (Right to Buy) | +26,179 | 26,179 | ||
| 2021-10-29 | Vizirgianakis Stavros G. Director | Grant or award · Stock Option (Right to Buy) | +6,544 | 6,544 | ||
| 2021-10-29 | Vizirgianakis Stavros G. Director | Grant or award · Stock Option (Right to Buy) | +19,634 | 19,634 | ||
| 2021-10-29 | Vizirgianakis Stavros G. Director | Grant or award · Stock Option (Right to Buy) | +34,905 | 34,905 | ||
| 2021-10-29 | Vizirgianakis Stavros G. Director | Grant or award · Stock Option (Right to Buy) | +347,323 | 347,323 | ||
| 2021-10-29 | Vizirgianakis Stavros G. Director | Grant or award · Stock Option (Right to Buy) | +89,001 | 89,001 | ||
| 2021-10-29 | Vizirgianakis Stavros G. Director | Grant or award · Stock Option (Right to Buy) | +261,794 | 261,794 | ||
| 2021-10-29 | Vizirgianakis Stavros G. Director | Grant or award · Restricted Stock Units | +2,895 | 2,895 | ||
| 2021-09-09 | Reali Kenneth Michael CHIEF EXECUTIVE OFFICER | Purchase | +1,800 | $14.81 | $27K | 11,175 |
| 2021-07-15 | Ladone Mary Kay Director | Grant or award · Restricted Stock Units | +5,440 | 5,440 | ||
| 2021-04-01 | Cowdy Philip G. Director | Grant or award · Restricted Stock Units | +2,700 | 0 | ||
| 2021-04-01 | STALNECKER SUSAN M Director | Grant or award · Restricted Stock Units | +23,416 | 23,416 | ||
| 2021-02-11 | Cowdy Philip G. Director | Grant or award · Restricted Stock Units | +9,000 | 0 |
Page 22 of 22 · 437 trades